Contrast Neurotoxicity Following Percutaneous Revascularization

González, Iria A.; Tapia, Cristina; Hernández-Luis, Carolina; Román, José Alberto San

doi:10.1016/s1885-5857(08)60242-x

Cited by 5 publications

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From the search results, we identified five case series and 38 case reports , for a total of 52 patients. The first published report documenting presumed CIE associated with cardiac catheterization dates from 1970 .…”

Section: Resultsmentioning

confidence: 99%

Contrast‐induced encephalopathy following cardiac catheterization

Spina

Simon

Markus

et al. 2016

Cathet Cardio Intervent

107

View full text Add to dashboard Cite

M a i l i n g A d d r e s s : F r e d e r i c o T. U l t r a m a r i @@@@@@@@@@@@@@@@@@@@@@@@@@@ It is estimated that 6,000 and 2,000 cardiac catheterization procedures per million inhabitants/year are performed in Western countries for diagnostic and therapeutic purposes. In order to perform these procedures, 1,800 tons of iodine are required all over the world to manufacture contrast media (CM). The number of procedures that require the use of contrast media (or dye) has increased over time, and the population submitted to it is growing older, presenting more comorbidities 1, 2. Currently low-osmolar contrast media are used in approximately 75% of patients and the iso-osmolar contrast media, allegedly less toxic are becoming more popular 1. In spite of development of new contrast media, they still represent the third main cause of nosocomial-acquired acute renal failure (ARF) (10% of cases), substantially increasing hospitalization period, care costs and in-hospital morbi-mortality 3-6. The main goal is to address important aspects about the contrast-medium induced nephropathy (CMIN) that follows cardiac catheterization, including its definition, pathogenesis, incidence, risk factors, clinical picture, prevention, treatment and prognosis.

show abstract

Section: Resultsmentioning

confidence: 99%

Contrast‐induced encephalopathy following cardiac catheterization

Spina

Simon

Markus

et al. 2016

Cathet Cardio Intervent

107

View full text Add to dashboard Cite

show abstract

“…In a patient with a neurological episode following catheterization, the most frequent etiology is ischemia. 5 After ruling out ischemia, neurological symptoms following coronary interventions may be due to contrast agents. Therefore, it is essential to have a computerized tomography (CT) or magnetic resonance (MR) imaging to exclude thromboembolic and hemorrhagic complications in a symptomatic patient.…”

Section: The Diagnosis Of Contrast-induced Neurotoxicitymentioning

confidence: 99%

The diagnosis of contrast-induced neurotoxicity

Kocabay

Karabay

2013

Vascular

View full text Add to dashboard Cite

Current awareness: Pharmacoepidemiology and drug safety

2008

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 23 sections: 1 Reviews; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Antidiabetic Agents; 21 Contrast Agents; 22 Bone Conservation Agents; 23 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

Contrast Neurotoxicity Following Percutaneous Revascularization

Cited by 5 publications

References 13 publications

Contrast‐induced encephalopathy following cardiac catheterization

Contrast‐induced encephalopathy following cardiac catheterization

The diagnosis of contrast-induced neurotoxicity

Current awareness: Pharmacoepidemiology and drug safety

Contact Info

Product

Resources

About